JP2009527533A5 - - Google Patents

Download PDF

Info

Publication number
JP2009527533A5
JP2009527533A5 JP2008555789A JP2008555789A JP2009527533A5 JP 2009527533 A5 JP2009527533 A5 JP 2009527533A5 JP 2008555789 A JP2008555789 A JP 2008555789A JP 2008555789 A JP2008555789 A JP 2008555789A JP 2009527533 A5 JP2009527533 A5 JP 2009527533A5
Authority
JP
Japan
Prior art keywords
methyl
fluorene
dione
tetrahydro
hydroxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008555789A
Other languages
English (en)
Japanese (ja)
Other versions
JP5349056B2 (ja
JP2009527533A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/051688 external-priority patent/WO2007096393A1/en
Publication of JP2009527533A publication Critical patent/JP2009527533A/ja
Publication of JP2009527533A5 publication Critical patent/JP2009527533A5/ja
Application granted granted Critical
Publication of JP5349056B2 publication Critical patent/JP5349056B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008555789A 2006-02-22 2007-02-21 Eg5キネシンモジュレーターとしてのインドロピリジン類 Expired - Fee Related JP5349056B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06110295 2006-02-22
EP06110295.0 2006-02-22
EP06119038.5 2006-08-16
EP06119038 2006-08-16
PCT/EP2007/051688 WO2007096393A1 (en) 2006-02-22 2007-02-21 Indolopyridines as eg5 kinesin modulators

Publications (3)

Publication Number Publication Date
JP2009527533A JP2009527533A (ja) 2009-07-30
JP2009527533A5 true JP2009527533A5 (cg-RX-API-DMAC7.html) 2013-02-07
JP5349056B2 JP5349056B2 (ja) 2013-11-20

Family

ID=37964159

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008555789A Expired - Fee Related JP5349056B2 (ja) 2006-02-22 2007-02-21 Eg5キネシンモジュレーターとしてのインドロピリジン類

Country Status (18)

Country Link
US (1) US8530493B2 (cg-RX-API-DMAC7.html)
EP (3) EP1996592B1 (cg-RX-API-DMAC7.html)
JP (1) JP5349056B2 (cg-RX-API-DMAC7.html)
KR (1) KR101415354B1 (cg-RX-API-DMAC7.html)
CN (1) CN101389628B (cg-RX-API-DMAC7.html)
AR (1) AR059609A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007217560B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0708233A2 (cg-RX-API-DMAC7.html)
CA (1) CA2643488C (cg-RX-API-DMAC7.html)
EA (1) EA015150B1 (cg-RX-API-DMAC7.html)
HK (1) HK1205510A1 (cg-RX-API-DMAC7.html)
IL (1) IL193625A (cg-RX-API-DMAC7.html)
MX (1) MX2008010801A (cg-RX-API-DMAC7.html)
NZ (1) NZ571357A (cg-RX-API-DMAC7.html)
TW (1) TWI377207B (cg-RX-API-DMAC7.html)
UA (1) UA96592C2 (cg-RX-API-DMAC7.html)
WO (1) WO2007096393A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200808070B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP2298311B1 (en) 1999-01-13 2012-05-09 Bayer HealthCare LLC w-Carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
DK1478358T3 (da) 2002-02-11 2013-10-07 Bayer Healthcare Llc Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
EP1636585B2 (en) 2003-05-20 2012-06-13 Bayer HealthCare LLC Diaryl ureas with kinase inhibiting activity
US20050192356A1 (en) * 2004-02-27 2005-09-01 Babish John G. Synergistic anti-inflammatory pharmaceutical compositions and methods of use
US7838524B2 (en) 2004-04-30 2010-11-23 Bayer Healthcare Llc Substituted pyrazolyl urea derivatives useful in the treatment of cancer
DE602005024572D1 (de) 2004-08-18 2010-12-16 4Sc Ag Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin
NZ589276A (en) 2005-02-03 2012-06-29 Topotarget Uk Ltd Combination therapies using hdac inhibitors and erlotinib (tarceva)
SI1901729T1 (sl) * 2005-05-13 2012-05-31 Topotarget Uk Ltd Farmacevtske formulacije HDAC inhibitorjev
CA2627923C (en) * 2005-11-10 2016-01-12 Topotarget Uk Limited Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer
EP2033962A1 (en) * 2007-08-22 2009-03-11 4Sc Ag Tetracyclic indolopyridines as EG5 inhibitors
CN101868446A (zh) * 2007-09-25 2010-10-20 托波塔吉特英国有限公司 某些异羟肟酸化合物的合成方法
EP2098524A1 (en) * 2008-03-05 2009-09-09 4Sc Ag Process for preparing enantiomerically pure indolopyrinidines
SI2262493T1 (sl) * 2008-03-07 2015-07-31 Onxeo Dk Branch Of Onxeo S.A. France Postopki zdravljenja z uporabo podaljšane kontinuirane infuzije belinostata
GB0900555D0 (en) * 2009-01-14 2009-02-11 Topotarget As New methods
CN109467555A (zh) * 2018-06-21 2019-03-15 广东蓝堡生物科技有限公司 一种他达那非衍生物及其制备方法和应用
CN109160914B (zh) * 2018-11-17 2020-06-16 重庆文理学院 一种双吲哚并吡啶类衍生物的合成方法及在抗肿瘤中的应用
CN111529526B (zh) * 2020-04-14 2021-04-23 广州领晟医疗科技有限公司 一种化合物在制备治疗急性胰腺炎的药物中的用途
CN113577063B (zh) * 2021-08-30 2022-08-16 广州领晟医疗科技有限公司 一种化合物在制备治疗炎性肠病的药物中的用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357122A3 (en) 1988-08-29 1991-10-23 Duphar International Research B.V Use of beta-carbolines, their bio-isosteric benzofuran and benzothiophene analogues for the manufacture of a medicament having cytostatic properties
GB9514473D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
DE19744257B4 (de) 1997-10-07 2004-04-15 Zentaris Gmbh Beta-Carboline und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen
US6890933B1 (en) 2000-02-24 2005-05-10 President And Fellows Of Harvard College Kinesin inhibitors
AU2002213421A1 (en) 2000-10-03 2002-04-15 Lilly Icos Llc Condensed pyridoindole derivatives
WO2002095361A2 (en) 2001-05-22 2002-11-28 President And Fellows Of Harvard College Identification of anti-protozoal agents
CA2460939C (en) 2001-09-19 2008-07-29 Pharmacia Corporation Substituted pyrazolyl compounds for the treatment of inflammation
EP2292615A1 (en) 2002-02-01 2011-03-09 AstraZeneca AB Quinazoline compounds
AU2003247891A1 (en) 2002-07-08 2004-01-23 Merck & Co., Inc. Mitotic kinesin binding site
US7022850B2 (en) 2003-05-22 2006-04-04 Bristol-Myers Squibb Co. Bicyclicpyrimidones and their use to treat diseases
JP4580932B2 (ja) 2003-06-12 2010-11-17 メルク・シャープ・エンド・ドーム・コーポレイション 有糸分裂キネシン阻害剤のプロドラッグ
CN1960725A (zh) 2004-03-15 2007-05-09 Ptc医疗公司 用于抑制血管发生的四环咔啉衍生物
DE602005024572D1 (de) * 2004-08-18 2010-12-16 4Sc Ag Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin
AU2006212863A1 (en) 2005-02-10 2006-08-17 Merck Sharp & Dohme Corp. Mitotic kinesin inhibitors
WO2007144384A1 (en) 2006-06-14 2007-12-21 4Sc Ag Pyrazolopyrimidones
WO2008006883A2 (en) 2006-07-13 2008-01-17 4Sc Ag Benzopyranopyrazoles

Similar Documents

Publication Publication Date Title
US12233052B2 (en) Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
JP7266630B2 (ja) ベンゾオキサゼピンオキサゾリジノン化合物及び使用方法
TW200932239A (en) PARP inhibitor compounds, compositions and methods of use
JP6522807B2 (ja) ベンゾオキサゼピンオキサゾリジノン化合物及び使用方法
CN120858101A (zh) 稠合四环类化合物、其制备方法及其在医药上的应用
IL193625A (en) History 10– (3 – Hydroxyphenyl) - 3a, 10,9,4 – Tetrahydro – 9,2, 10a– Triaza – Cyclopenta [b] Fluorene – 3,1 – Dione, Pharmaceutical preparations containing them and their use in the preparation of a drug for the treatment of responding diseases For inhibition of quinazine eg5
CN106860870B (zh) 抗肿瘤生物碱的联合治疗
CN102395372B (zh) 用于治疗造血组织肿瘤和白血病的苯并二氮*衍生物
TWI641374B (zh) 含低用量伊立替康鹽酸鹽水合物之抗腫瘤劑
CN120365289A (zh) 稠环类化合物、其制备方法及其在医药上的应用
CA3239205A1 (en) Combination therapy comprising an fgfr inhibitor and a kras inhibitor
JP2008534637A5 (cg-RX-API-DMAC7.html)
CA3011289A1 (en) Compounds for inhibiting cancer and virus
HK40042000B (en) Benzoxazepin oxazolidinone compounds and methods of use
HK40042521B (en) Benzoxazepin oxazolidinone compounds and methods of use
AU2012308414A1 (en) Phosphatidylinositol 3-kinase inhibitors for the treatment of cancer
HK1254517B (en) Benzoxazepin oxazolidinone compounds and methods of use